Thomas Fischer

60PUBLICATIONS
306CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Jun 21, 2026
The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO).

|Jun 21, 2026
Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025.

|Jun 11, 2026
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with Ruxolitinib.

|Jun 03, 2026
Type I interferon-activated NK cells control polycythemia vera in vivo.

|May 23, 2026
Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP).

|May 05, 2026
MDM2 inhibitors in myeloid cancers: from basic biology to clinical use in myeloproliferative neoplasms.

Pageof 10

Frequent Collaborators

7 joint publications

Francesca Palandri

5 joint publications

Massimo Breccia

5 joint publications

Mario Tiribelli

5 joint publications

Felicitas Thol